<DOC>
	<DOCNO>NCT01422096</DOCNO>
	<brief_summary>This study test whether short-term suppression ovarian function ameliorate androgen ( male hormone ) overproduction overweight girl androgen excess . The investigator hypothesize one dose depot leuprolide agonist administration improve androgen level girls ovarian androgen overproduction . Specifically , intervention improve androgen level ovarian stimulation test recombinant human chorionic gonadotropin ( rhCG ) .</brief_summary>
	<brief_title>Effect Short Term Ovarian Suppression Androgen Overproduction Overweight Girls With Androgen Excess</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Hyperandrogenism</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>overweight ( &gt; 85th BMI % ) females Early late puberty ( expect age range 718 ) Hyperandrogenemic ( free testosterone great 2.5 standard deviation mean normal control subject Tanner Stage ) Screening lab within ageappropriate normal range , exception mildly low hematocrit ( see ) hormonal abnormality inherent obesity could include mildly elevated luteinizing hormone ( LH ) , lipid , testosterone , prolactin , DHEAS , E2 , glucose , insulin decrease folliclestimulating hormone ( FSH ) and/or sex hormonebinding globulin ( SHBG ) Screening labs outside ageappropriate normal range Hemoglobin &lt; 12 mg/dL hematocrit &lt; 36 % ( Subjects offer opportunity take iron supplementation 60 day hematocrit slightly low ( 3336 % ) ( suggestive iron deficiency anemia ) return retesting hemoglobin/hematocrit . If still &lt; 36 % , exclude . ) Morning Cortisol &lt; 5 g/dL 17hydroxyprogesterone &gt; 295 ng/dL History Cushing 's syndrome adrenal insufficiency Pregnant</criteria>
	<gender>Female</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>